Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. - Wikidata - awgldk - TriplyDB

Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters.

Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters.

http://www.wikidata.org/entity/Q33921227

about

Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy.Use of third line antiretroviral therapy in Latin America Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study.Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment.Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.Preventing HIV Transmission Among Partners of HIV-Positive Male Sex Workers in Mexico City: A Modeling Study Temporal Trends in Age at HIV Diagnosis in Cohorts in the United States, the Caribbean, and Central and South America.CD4 Counts at Entry to HIV Care in Mexico for Patients under the "Universal Antiretroviral Treatment Program for the Uninsured Population," 2007-2014 Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model.Examining Adherence Among Challenging Patients in Public and Private HIV Care in Argentina.Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America HIV Phylogeographic Analyses and Their Application in Prevention and Early Detection Programmes: The Case of the Tijuana-San Diego Border Region [Barriers to adherence and retention in public and private healthcare according to patients and health workers].Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.Patient-provider perceptions on engagement in HIV care in Argentina.Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas.Missed opportunities for HIV control: Gaps in HIV testing for partners of people living with HIV in Lima, Peru Late Diagnosis Due to Missed Opportunities and Inadequate Screening Strategies in HIV Infected Mexican Women.Cryptococcosis in Acquired Immunodeficiency Syndrome Patients Clinically Confirmed and/or Diagnosed at Necropsy in a Teaching Hospital in Brazil.Evaluating the care cascade after antiretroviral therapy initiation in Latin America.Implementation and uptake of the Conexiones y Opciones en la Argentina intervention: feasibility and acceptability 'Proyecto Orgullo', an HIV prevention, empowerment and community mobilisation intervention for gay men and transgender women in Callao/Lima, Peru.The odyssey of linking to and staying in HIV care among male sex workers in Peru.Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America.Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.Evolutionary history and spatiotemporal dynamics of the HIV-1 subtype B epidemic in Guatemala

P2860

Q28536797-E45DC5EF-24F5-44F1-AB91-A76E4A124C58 Q33803185-15BE44B8-287C-4E39-8812-F45B183EBC56 Q33834625-80498CDD-27C6-49E8-A964-200AB87EC247 Q34183261-8EA976E0-6886-465C-8E40-1108620DC0EC Q34420990-EED0ADBC-50A0-4124-9398-65A9260E0757 Q34528801-5FDC687E-C1E0-4683-9BE2-184884EFD88C Q34963393-E27BB79B-E465-44F0-A0D1-BB8200EF9F13 Q35778777-F1D7B880-95A8-4D49-9C9A-D78ECEFCD166 Q35828822-858ADDA1-F7AB-44EB-AE39-FFA34537E132 Q35883370-AAE5F519-BD4F-43CF-90AB-C5DD361ACD72 Q35973691-0C456AE4-5363-40CA-BE9F-24FC308FA18C Q35991395-D063240C-26F5-4BFF-B2A0-18D772F1424F Q36005788-CC6A8A4F-CABB-49B7-9262-12C88C0EDEF7 Q36043414-93E93CB4-4BAB-42D9-91B5-1B885F0B9D06 Q36251937-AC5A405F-E576-4F18-903B-51EB5BFA885C Q36575507-4D8034B7-880E-4E08-B3C2-1FF3EFE31558 Q37105884-E184C6F6-5C38-42B2-99B3-12C92412BCE4 Q37489326-0E9CDFCC-DD85-4CE2-9090-2D450688BEA9 Q37665311-BD39573A-96B5-4D4E-AA49-FD2CAC261E13 Q38625144-A18685D0-F38E-44EF-B0C5-9D614AD3D460 Q38625801-4789C4FF-6E38-4CA0-92C6-397E06CDC419 Q39368724-80902CF2-46B3-4280-8DCA-F71C498D386B Q39560173-11EE959A-14B4-4BCF-BC9C-4CA5AE548729 Q39600584-81ADA749-7C64-4250-B4E1-C4771FF25176 Q39817254-0499C2A4-98B5-41B4-BAB1-963F340A109A Q41168725-DFBBFD93-EB7C-41B4-AF9E-5A3BF0E59473 Q45998765-78488BF1-E5AB-47E2-BEA9-C846D2CF89FB Q52661543-4D7E090E-FA0B-4BF2-9622-2E7C91D5AAB8 Q53821839-BFD84903-9A15-4115-B4B9-E587D54AECC6 Q58744091-E3BFF036-2F00-4AC1-8B67-47C311D21C04

P2860

Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters.

http://www.wikidata.org/entity/Q33921227

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cross-sectional analysis of la ...... e testers and late presenters.

@ast

Cross-sectional analysis of la ...... e testers and late presenters.

@en

type

label

Cross-sectional analysis of la ...... e testers and late presenters.

@ast

Cross-sectional analysis of la ...... e testers and late presenters.

@en

prefLabel

Cross-sectional analysis of la ...... e testers and late presenters.

@ast

Cross-sectional analysis of la ...... e testers and late presenters.

@en

P1433

Q33921227-0E338A1F-2C55-442E-A294-7617B717A139

P1476

Q33921227-CBFC36A7-4073-4354-91C8-5296E09E986D

P2093

Q33921227-09BC37F6-ABAE-4529-BA52-0E44D30E9BD5

Q33921227-190D79F9-8BA7-4565-9A7C-430630937886

Q33921227-45BE7226-7263-40E2-875F-06F0A978E231

Q33921227-55A19CD9-F952-4C61-BFFC-4B7DB4F0BD42

Q33921227-5BE0A382-3617-4EC8-89B0-514D2EF903D2

Q33921227-A520B26C-458A-459D-B82E-68A7B3F52477

Q33921227-B61B9387-652C-4C52-AB3B-F79D7E803576

Q33921227-D3E34780-551C-447B-A1B5-9E7250321EE2

Q33921227-F165055C-771B-4072-9AD9-5280664E3CC3

P2860

Q33921227-0875F2CD-17CF-46E4-AF4F-9F05CD29D1DB

Q33921227-23302C13-3723-4EC9-8F12-009AB30915A7

Q33921227-2C79AC2C-9105-4209-8E68-EDD2277FE615

Q33921227-3644C259-6A50-4D94-A41F-7F5ED6735AA1

Q33921227-408B7B48-FE74-4F94-A67E-CF108BAAD9B3

Q33921227-424F19B3-9891-4286-9EE5-CF9FA5689773

Q33921227-5EF4C563-8AA6-429E-9BDA-74DCFFAF84F7

Q33921227-620D62BC-C5A4-4844-B9D0-75B71416A277

Q33921227-66B5D2E3-0230-4446-A195-AA8E27F15869

Q33921227-686090F3-9F8D-40B4-A079-31193815D581

P304

Q33921227-F8691728-5F24-4E6F-98D6-AC5C253F6AD1

P31

Q33921227-3EE0FB0B-3973-4707-9103-156E2E848540

P356

Q33921227-342DBA12-B8FC-4CE9-B4E6-92675F303C22

P407

Q33921227-827D1527-F87A-492B-AF20-B750C3A33806

P433

Q33921227-F5BD0EC4-6455-4842-8704-5923473F1854

P478

Q33921227-ABC79E91-6D6A-4F02-93C6-BFF88B56E82C

P50

Q33921227-2B576861-06B1-490A-BC7B-D1AA66D6A703

Q33921227-4D385022-E0CA-4CCF-A7F4-94DF8A2018B1

Q33921227-632DD28A-5976-41EB-A437-570739B7398A

Q33921227-88D6D134-647C-4093-B1A8-08A3B4B09767

Q33921227-A3DC2E1D-8963-4CF8-9AEF-9D12F47F99A3

P577

Q33921227-EACBD9DE-A568-4E6B-B126-15C41300EA35

P5875

Q33921227-1AC4B6AB-A7D6-4C42-8117-E9A7BE2CA1F0

P698

Q33921227-57A66A5B-0A7C-4A00-ADA9-4AC779D1C577

P932

Q33921227-626F64AC-A5AC-46E6-B80B-DDB983C852BC

P356

JOURNAL.PONE.0020272

P1433

P1476

Cross-sectional analysis of la ...... e testers and late presenters.

@en

P2093

Bryan E Shepherd

http://www.w3.org/2001/XMLSchema#string

CCASAnet Team

http://www.w3.org/2001/XMLSchema#string

Carina Cesar

http://www.w3.org/2001/XMLSchema#string

Claudia Cortés

http://www.w3.org/2001/XMLSchema#string

Daniel Masys

http://www.w3.org/2001/XMLSchema#string

Eduardo Gotuzzo

http://www.w3.org/2001/XMLSchema#string

Juan Sierra-Madero

http://www.w3.org/2001/XMLSchema#string

Pedro Cahn

http://www.w3.org/2001/XMLSchema#string

Serena Koenig

http://www.w3.org/2001/XMLSchema#string

P2860

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

Meta-analysis in clinical trials

Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa.

Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Late presentation for human immunodeficiency virus care in the United States and Canada.

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

P304

e20272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0020272

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Brenda Crabtree-Ramírez

Yanink Caro-Vega

Catherine C. McGowan

P577

2011-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51188191

http://www.w3.org/2001/XMLSchema#string

P698

21637802

http://www.w3.org/2001/XMLSchema#string

P932

3102699

http://www.w3.org/2001/XMLSchema#string